Infective Endocarditis Due to Penicillin-Resistant Viridans Group Streptococci
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The emergence of viridans group streptococci that are relatively or fully resistant to penicillin is increasingly being recognized worldwide, but only a scant number of penicillin-resistant isolates have been described as a cause of infective endocarditis. Because of the paucity of data, it has been difficult to define optimal treatment regimens for this syndrome. Thus, recommendations for therapy have largely been made on the basis of consensus opinion. METHODS: We retrospectively identified a cohort of patients with infective endocarditis due to penicillin-resistant viridans group streptococci who were seen at the Mayo Clinic (Rochester, MN) between January 1967 and April 2006. Demographic characteristics, clinical features, treatment regimens, and outcomes were analyzed. Mean values are shown with standard deviations. RESULTS: Twenty-nine patients were identified over the 38.5-year study period. Nineteen patients with native valve endocarditis were cured; 9 of these 19 patients received a 2.3+/-0.4-week antibiotic regimen consisting of penicillin and an aminoglycoside, and 8 of these 19 patients received treatment courses of 5.1+/-1.4 weeks' duration that consisted of either a bimodal combination regimen with a penicillin or ceftriaxone and an aminoglycoside or ceftriaxone monotherapy. Nine of 10 patients with prosthetic valve infection were cured with 4.1+/-0.6-week regimens that consisted of either a combination regimen or monotherapy with vancomycin or ceftriaxone. Mean duration of follow-up after hospital discharge was 9.1 years. CONCLUSIONS: Outcomes of this relatively large population of patients with endocarditis with a prolonged duration of follow-up indicate that the application of current treatment guidelines should be successful in most patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis
Li, J. S., Sexton, D. J., Mick, N., Nettles, R., Fowler, V. G., Ryan, T., Bashore, T., & Corey, G. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313753 · Cited by 4,027
Durack, D. T., Lukes, A. S., Bright, D. K., & Service, D. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90143-0 · Cited by 2,572
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Self-citationInfective Endocarditis in Adults
Mylonakis, E., & Calderwood, S. B. (2001) · New England Journal of Medicine · doi:10.1056/nejmra010082 · Cited by 1,324
Temporal Trends in Infective Endocarditis: A Population-Based Study in Olmsted County, Minnesota
Tleyjeh, I. M., Steckelberg, J. M., Murad, H. S., Anavekar, N. S., Ghomrawi, H. M. K., Mirzoyev, Z., Moustafa, S. E., Hoskin, T. L., Mandrekar, J. N., Wilson, W. R., et al. (2005) · JAMA · doi:10.1001/jama.293.24.3022 · Cited by 366
Self-citationDoern, G. V., Ferraro, M. J., Brueggemann, A. B., & Ruoff, K. L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.4.891 · Cited by 297
Journal of microbiology, immunology and infection : Wei mian yu gan ran za zhi.
hui, Z. M. W. S. W. X., hui, Z. M. M. Y. X., hui, Z. M. G. R. Z. Y. X., hui, T. G. R. Z. Y. X., & ScienceDirect (1998) · Cited by 159
Marron, A., Carratala, J., Gonzalez-Barca, E., Fernandez-Sevilla, A., Alcaide, F., & Gudiol, F. (2000) · Clinical Infectious Diseases · doi:10.1086/317460 · Cited by 149
Teng, L. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/41.6.621 · Cited by 129
Alcaide, F., Liñares, J., Pallarés, R., Carratalà, J., Benítez, M. Á., Gudiol, F., & Martin, R. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.10.2243 · Cited by 108
Wisplinghoff, H., Reinert, R. R., Cornely, O., & Seifert, H. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.6.1876-1880.1999 · Cited by 97
THE RISKS OF DENTAL EXTRACTION DURING PENICILLIN TREATMENT
GARROD, L. P., & WATERWORTH, P. M. (1962) · Heart · doi:10.1136/hrt.24.1.39 · Cited by 91
Endocarditis Due to Resistant Viridans Streptococci during Oral Penicillin Chemoprophylaxis
Parrillo, J. E., Borst, G. C., Mazur, M. H., Iannini, P. B., Klempner, M. S., Moellering, R. C., & Anderson, S. E. (1979) · New England Journal of Medicine · doi:10.1056/nejm197902083000608 · Cited by 85
Prabhu, R. M., Piper, K. E., Baddour, L. M., Steckelberg, J. M., Wilson, W. R., & Patel, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4463-4465.2004 · Cited by 67
Self-citationIn vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures
Potgieter, E., Carmichael, M., KOORNHOF, H. J., & Chalkley, L. J. (1992) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01960811 · Cited by 65
Levy, C. S., Kogulan, P., Gill, V. J., Croxton, M. B., Kane, J. G., & Lucey, D. R. (2001) · Clinical Infectious Diseases · doi:10.1086/321910 · Cited by 57
Spanik, S., Trupl, J., Kunova, A., Botek, R., Sorkovska, D., Grey, E., Studena, M., Lacka, J., Oravcova, E., Krchnakova, A., et al. (1997) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549709019036 · Cited by 42
The risk of bacterial endocarditis during antirheumatic prophylaxis.
Doyle, E. F., Spagnuolo, M., Taranta, A., Kuttner, A. G., & Markowitz, M. (1967) · PubMed · Cited by 41
Treatment of Infective Endocarditis
Kaye, D. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-6-199603150-00011 · Cited by 41
Endocarditis Due toStreptococcus mitiswith High-Level Resistance to Penicillin and Cefotaxime
Lonks, J. R., Dickinson, B. P., & Rúnarsdóttir, V. Á. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910143411616 · Cited by 33
Apparent Failure of Endocarditis Prophylaxis Caused by Penicillin-Resistant Streptococcus mitis
Hall, G. E., & Baddour, L. M. (2002) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200207000-00008 · Cited by 31
Self-citationEndocarditis Due to Streptococcus mitis With High-Level Resistance to Penicillin and Ceftriaxone
Sabella, C. (2001) · JAMA · doi:10.1001/jama.285.17.2195 · Cited by 28
Prosthetic-Valve Endocarditis Caused by Penicillin-Resistant Streptococcus mitis
Levitz, R. E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906103402319 · Cited by 27
Shelburne, S. A., Greenberg, S. B., Aslam, S., & Tweardy, D. J. (2007) · Journal of Infection · doi:10.1016/j.jinf.2006.05.010 · Cited by 23
Mrázová, M., Docze, A., Buckova, E., Bucko, L., Kacmarikova, M., Grey, E., Korcova, J., Koprnova, J., Saboova, Z., Beno, P., et al. (2005) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540510043266 · Cited by 19
Endocarditis caused by penicillin-resistant Streptococcus mitis in a 12-year-old boy.
Huang, I., Chiou, C. C., Liu, Y.-C., & Hsieh, K. (2002) · PubMed · Cited by 18
Penicillin Resistance in Viridans Streptococcal Bacteremia is Related with High Mortality
Docze, A., Mraz, M., Grey, E., Bucko, E., Korcova, J., Svetlansky, I., & Sabo, Z. (2003) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540310016727 · Cited by 6
Marx, G. F. (1967) · JAMA · doi:10.1001/jama.201.1.129 · Cited by 2
Cited by
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J.-P., Del Zotti, F., Dulgheru, R., El Khoury, G., Erba, P. A., Iung, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv319 · Cited by 4,997
“Treatment outcomes were similar in PVE and NVE.(145) Hence antibiotic therapy for penicillin-resistant and penicillin-susceptible oral streptococci is qualitatively similar (Table 16).”
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Self-citationGuidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)
Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer, Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp285 · Cited by 2,014
2023 ESC Guidelines for the management of endocarditis
Delgado, V., Ajmone Marsan, N., de Waha, S., Bonaros, N., Brida, M., Burri, H., Caselli, S., Doenst, T., Ederhy, S., Erba, P. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad193 · Cited by 1,754
Self-citationGould, F. K., Denning, D. W., Elliott, T. S. J., Foweraker, J., Perry, J. D., Prendergast, B. D., Sandoe, J. A. T., Spry, M. J., & Watkin, R. W. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr450 · Cited by 593
Metadata
- Authors
- Knoll, B., Tleyjeh, I. M., Steckelberg, J. M., Wilson, W. R., & Baddour, L. M.
- Affiliations
- Mayo Clinic (US)
- King Fahd Medical City (SA)
- Corresponding author
- Knoll, B.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-06-15
- Volume
- 44
- Issue
- 12
- Pages
- 1585-1592
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2155164226
- Semantic Scholar
- d87aa556a8baf60eef6127697f581d185034d192
- Cited by
- 70
- References
- 29
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 6 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 5 · 2018: 1 · 2017: 1 · 2016: 2 · 2015: 5 · 2014: 1 · 2013: 4 · 2012: 5
- FWCI
- 3.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Mayo Clinic
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- infective endocarditis, Streptococcus viridans, penicillin resistance, antibiotic regimens, ceftriaxone, vancomycin, aminoglycosides, native valve endocarditis, prosthetic valve endocarditis, treatment outcomes
- MeSH terms
- Adult, Aged, Cross Infection, Endocarditis, Bacterial, Female, Heart Valve Prosthesis, Hospitals, Teaching, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Penicillin Resistance, Retrospective Studies, Streptococcal Infections, Cohort Studies, Treatment Outcome, Practice Guidelines as Topic, Community-Acquired Infections, Disease-Free Survival, Viridans Streptococci
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.